adenocarcinoma lung cancer - Yahoo Search Results

Ads
related to: adenocarcinoma lung cancer
Official ES-SCLC Therapy Site - What To Expect With Treatment

www.es-sclc-treatment.com
Downloadable Resources For Patients With Extensive Stage Small Cell Lung Cancer. Learn More About What To Expect With Your ES-SCLC Treatment Journey.
FDA Approved Treatment · Clinical Study Results · Medication Guide · Important Safety Info
How Treatment Works
See Possible Treatment Side Effects

And Important Safety Information.

Clinical Study Results
Review Data From Clinical Trials

And Find Efficacy & Safety Info.

About SCLC
Learn About Small Cell Lung Cancer

At The Official Patient Website.

Access & Support
Get Personalized Patient Support

That You Can Count On.

FDA Approved Treatment
Discover More About FDA Approved

Treatment For Patients With ES-SCLC

Download Resources
Find Supportive Patient Information

And Download Available Resources.
Non-Small Cell Lung Cancer - Official Patient Website

patient-therapy-nsclc.com
Discover Info On A Non-Small Cell Lung Cancer Treatment At The Official Patient Website. Visit An Official Patient Website To Get Resources For Patients & Learn About NSCLC.
Types: Side Effects Information, Dosing Schedule, Medication Guide, About NSCLC

Search results

- Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
  Zacks· 1 day ago
  Gilead (GILD) and partner Arcus Biosciences (RCUS) present data from metastatic colorectal cancer and gastrointestinal cancer study.
- EMA Panel Nods to Seven New Cancer Drugs
  Medscape· 4 days ago
  The drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
- 'Outstanding' 5 Year PFS With Lorlatinib in ALK+ NSCLC
  Medscape· 3 days ago
  Five-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some experts question the use of crizotinib as the comparator drug.
- Gilead and Cartography enter deal to develop cancer therapies
  Pharmaceutical Technology via Yahoo Finance· 6 days ago
  The alliance aims to create treatments for triple-negative breast cancer and adenocarcinoma, the...
- CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
  Benzinga· 3 days ago
  Sugemalimab is expected to become the first anti-PD-L1 monoclonal antibody (mAb) in the world approved in Europe for both first-line squamous and non-squamous NSCLC, regardless of PD-L1 expression ...
- 'I'm upset and angry': Greater Cincinnati woman learns she has cancer over email
  Local 12 Cincinnati· 7 days ago
  Two million Americans will learn they have cancer this year -- many of them via email. Instead of a...
- 'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
  MedPage Today· 2 days ago
  EGFR testing now needed for all patients with stage III disease, experts say
- ASCO: Early Purple data gain ground in metastatic pancreatic cancer
  FierceBiotech· 3 days ago
  Purple Biotech hopes its lead asset against metastatic pancreatic cancer will one day show its true...
- ...-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon ...
  KOIN News 6 Portland· 2 days ago
  Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
- Small Business - Cordele Dispatch | Cordele Dispatch
  Cordele Dispatch· 6 days ago
  Sixteen Researchers from Florida Cancer Specialists & Research Institute Share Cancer Care Discoveries at 2024 ASCO® Annual Meeting PR Newswire FORT MYERS ...